Stay ahead with breaking tech news, gadget reviews, AI & software innovations, cybersecurity tips, start‑up trends, and step‑by‑step how‑tos.
Charlène and Billie go lighting. The girls want to test Alexandre before he meets Jude. Of course, they want to make sure he’s not a psychopath. What is certain is that they are not insensitive to his charm. Spoiler for episode 646 of Here it all begins. Find “Here everything begins”, Monday to Friday at 6:35 p.m. on TF1.
SOLANA BEACH, California, April 13, 2023 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global platform company that provides brain navigation and delivery, today announced the successful registration of its Neuro Navigation portfolio with the Brazilian regulatory body, Agência Nacional de Vigilância Sanitária (ANVISA) .
“I had the opportunity to see the ClearPoint Neuro Navigation System in action several times and was thrilled to learn that it was finally approved by the Brazilian regulatory agency,” said Raquel Rodrigues, MD, M.Sc, Pediatric Neurosurgeon and Neuro-oncologist in Brazil. “With a very intuitive interface and software, I personally believe that it is easy to manage its features, even for a neurosurgeon only trained in traditional neuro navigation methods. With ClearPoint we plan, for the first time in Latin America, to offer our patients unprecedented medical treatments, such as Convection Enhanced Delivery (CED) for brain cancer and neurodegenerative disorders with intra-procedural guidance by magnetic resonance imaging. Furthermore, with this system we hope to refine our DBS implants, deep brain biopsies and laser ablations. I am honored to lead the neurosurgical team that will perform the first neurosurgery with this splendid technology here in Brazil”.
“We are incredibly proud to have achieved ANVISA approval following an extensive review,” explained Megan Faulkenberry, Vice President of Quality at ClearPoint Neuro. “Our first approval in Latin America is an important milestone that supports our 4th pillar of growth: international expansion”. Every global approval we gain helps us and our pharmaceutical partners deliver new therapies, both clinically and in clinical trials, to patients with some of the most devastating neurological diseases.”
About ClearPoint Neuro
ClearPoint Neuro’s mission is to improve and restore the quality of life for patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the company’s current product portfolio include deep brain stimulation, laser ablation, biopsy, and drug delivery, biology, and brain gene therapy. The ClearPoint® Neuro Navigation System is FDA cleared, CE marked, and installed in over 65 locations in North America, Europe, and South America. ClearPoint Neuro partners with more than 50 biological/pharmaceutical companies, academic centers, and contract research organizations, providing solutions for the direct delivery of CNS therapeutics in preclinical studies and clinical trials worldwide. To date, over 6,000 procedures have been performed and supported by the company’s team of clinical experts, who provide support and services to our customers and partners. For more information, please visit www.clearpointneuro.com.
Forward-looking Statements
Statements in this press release regarding the Company’s plans, growth and strategies may be forward-looking statements within the context of federal securities laws. Statements regarding the Company’s future events, developments and future performance, the size of the total addressable markets or market opportunity for the Company’s products and services, as well as management’s expectations, beliefs, plans, estimates or projections relating to the future , are forward-looking statements within the meaning of these laws. Uncertainties and risks might cause the Company’s actual results to differ materially from those expressed or implied by forward-looking statements. Particular uncertainties and risks include those related to: the impact of the COVID-19 pandemic, global instability, supply chain disruptions, labor shortages, and macroeconomic and inflationary conditions; future revenues from sales of the Company’s ClearPoint Neuro Navigation System and other new products offered by the Company; the Company’s ability to market, market and achieve broader market acceptance of the Company’s ClearPoint Neuro Navigation System and other new products offered by the Company; the ability of our biological partners and drug distributors to achieve commercial success, including the use of our products and services in their delivery of therapies; and risks inherent in the research, development and regulatory approval of new products. More detailed information regarding these and additional factors that might affect the Company’s actual results are described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with Securities and Exchange Commission.
An image accompanying this announcement is available at
Contato: Contato para os media – ClearPoint Neuro Jacqueline Keller, Vice-presidente de Marketing 949-900-6833 [email protected] Relações com Investidores – ClearPoint Neuro Caroline Corner, PhD ICR Westwicke [email protected]
GLOBENEWSWIRE (Distribution ID 8804250)
Together with the new Leica M11 Monochrom digital rangefinder camera for black-and-white photos (reported internally), the «Summilux-M 50 f/1.4 ASPH.» also presented a new normal lens in an improved version. In addition to the usual high image quality for high-contrast and detailed images, the 50mm now offers a shorter close-up limit of 45cm (instead of 70cm as before) and 11 aperture slats (previously 9) for a rounder bokeh. In addition, a sun visor is now integrated.
Leica Camera AG has shaped the world of photography more than once. One of these sensations was the introduction of the Leica M series in 1954, which is still making history today with M cameras and lenses. One of the legendary M lenses has now been further developed and presents itself with the latest high-end technology while remaining compact and lightweight: the Leica Summilux-M 50 f/1.4 ASPH. It is the classic among the high-speed normal lenses and the new, improved edition offers even more flexibility and freedom when taking photos.
The classic has been relaunched and adapted to the times: The fast 50mm normal lens now offers a shorter close-up limit of 45cm and 11 aperture slats for a rounder bokeh as well as an integrated, extendable sun visor.
With its standard focal length of 50 mm, the new Summilux-M is suitable for almost every photographic situation. Like all M lenses, it is characterized by the unmistakably high image quality. The new Summilux-M exploits the full performance potential of new camera image sensors and offers exceptionally high-contrast and detailed image results even in difficult lighting conditions. In addition, 11 instead of the previous 9 aperture blades ensure a visibly rounder bokeh.
The close-up limit has also been extended, from 70 cm to 45 cm. This was only made possible by the double cam gear specially developed by Leica engineers. As a result, the angle of rotation of the distance ring has been greatly expanded compared to the previous model, making focusing even more precise over the entire adjustment range. Neither the size nor the sensitivity of the focusing was changed, which means that the lens is easy to handle even when focusing in the extended close-up range. Focusing takes place up to 70 centimeters as usual via the rangefinder of the digital and analogue M cameras. To focus in the extended close-up range between 70 and 45 centimetres, the live view on the screen, the Visoflex or the mobile app “Leica FOTOS” must be used following a slight resistance.
Instead of just 70cm as before, the new Summilux-M 50 f/1.4 ASPH. now focus up to 45cm. Since the rangefinder does not work at such a short distance, focusing in this extended close-up range is done via the electronic viewfinder image of a digital M camera – i.e. via the LCF, the optional electronic attachable viewfinder or, in remote operation, via a smartphone with the “Leica FOTOS” app installed .
Like the 35mm from the fast Summilux-M series, the Summilux-M 50 f/1.4 ASPH. a technical and optical advancement. The lens hood also has a round design with the 50 mm focal length. Integrated directly in the lens, it can be screwed in or out at any time with just one movement. Like the previous model, the new Summilux-M 50 f/1.4 ASPH. Available in two versions, silver or black anodized.
The focal length classic is suitable for all current and future M cameras. In combination with the M-Adapter L, the Summilux-M also enables photography and filming with the mirrorless cameras of the SL series (Leica SL2 and SL2-S).
The Leica Summilux-M 50 f/1.4 ASPH. is now available worldwide in all Leica Stores, in the Leica Online Store and in specialist shops. The recommended retail price including VAT is CHF 4,780 for the black M lens and CHF 4,990 for the silver version.
Leica Summilux-M 1:1,4/50 ASPH. (product page)
Leica M11 monochrome (product page)
Leica M-System (overview page)
Leica Camera (Switzerland)
CH-2560 Nidau
Tel. 032 332 90 90
| Leica Summilux-M 1:1.4/50 ASPH. – Specifications | |
| Order number | Silver chrome: 11 729 Black anodized: 11 728 |
| angle of view (for 35mm 24 x 36 mm) | Diagonal/horizontal/vertical: 45.4°/38.4°/26.1° |
| optical construction | 8 lenses in 5 groups |
| Number of aspherical surfaces | 1 |
| Position of the entrance pupil in front of the bayonet | 25,4 mm |
| focus workspace | Live View: 0,45 m bis ∞, Messsucher: 0,7 m bis ∞ |
| Distance setting scale | Combined division meter (m)/feet (ft) |
| Smallest Object Field | Small picture: 153 x 229 mm |
| Largest scale | 1:6,4 |
| Aperture setting/function | Locking aperture, adjustable in half steps |
| Smallest Aperture | 16 |
| Number of aperture blades | 11 |
| bayonet | Leica M bayonet with 6-bit coding |
| filter thread | E46 |
| lens hood | Integrated, extendable |
| Long | Ca. 59,3 mm |
| diameter | Ca. 58,6 mm |
| Weight | Ca. 337g |
.
Xiaomi Just came out to confirm that Xiaomi 13 Ultra will have an official launch event in China on April 18, 2023.
Xiaomi reveals the specifications of the Xiaomi 13 Ultra camera, full of 50MP, all 4 main cameras, 1-inch IMX989 sensors
Confirmed! Xiaomi 13 Ultra Launched on April 18, ready to release sample photos from the camera to watch.
Recently, the company has further confirmed that the Xiaomi Pad 6 Series tablets and the new Xiaomi Smart Band 8 will also be unveiled at the event.
The teaser of the Xiaomi Pad 6 Series that has been released shows the design of this tablet. which comes in an elegant style Aluminum back cover with similar camera modules on Xiaomi 13 and Xiaomi 13 Pro phones
It also reveals that the Xiaomi Pad 6 will use a Snapdragon 870 chip, while the Xiaomi Pad 6 Pro will use a Snapdragon 8+ Gen 1 chipset.
For the Xiaomi Smart Band 8 teaser that has been released, it also shows the design of this smart band as well. Which still adheres to the same style as the previous model, but seems to focus on a variety of watch straps and add more fashion
For the Xiaomi 13 Ultra, Xiaomi Pad 6 Series and Xiaomi Smart Band 8 launch event will be held in China on April 18, 2023 at 7:00 p.m. local time or 6:00 p.m. Thailand time. Let’s wait and follow.
Xiaomi 13 Ultra renders reveal a prominent convex rear camera area before launch next week
Leaked price of Xiaomi 13 Ultra as the top flagship The specification starts knocking at 31,xxx baht.
Xiaomi-Leica confirms the Xiaomi 13 Ultra will launch internationally this April and feature a new Summicron lens.
